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Background
HIV-1 subtype C is the predominant subtype in India and
South Africa (SA) responsible for explosive epidemics. An
understanding of the neutralization sensitivity of viruses
from these regions will help to define shared epitopes in
the envelope protein, which may be important for inclu-
sion in an effective subtype C-specific vaccine.
Methods
Plasma from 44 chronically HIV-1 subtype C infected
SA individuals in the CAPRISA 002 Acute Infection
cohort were used to assess the neutralization sensitivity
of 10 SA and 9 Indian Tier 2 viruses in a TZM-bl assay.
Intra-subtype neutralization activity between SA and
Indian viruses was determined. The envelope sequence
of the Indian panel was analyzed in order to identify
epitopes known to be targeted by the neutralizing anti-
bodies in a subset of the CAPRISA plasmas.
Results
South African and Indian viruses were generally sensitive
to the most potent plasmas. However, SA viruses showed
overall greater sensitivity compared to Indian viruses; neu-
tralization of 50% of the SA virus panel was achieved by
15/44 (34%) of the plasmas compared to only 6/44 (14%)
against the Indian panel. Furthermore, neutralization titers
against SA viruses were higher, with 9/44 (21%) of plasmas
neutralizing at >1:200 compared to 5/44 (11%) against the
Indian panel. An analysis of the gp160 sequences sug-
gested that genetic differences in key neutralization epi-
topes between SA and Indian viruses were in part
responsible for differences in sensitivity.
Conclusion
These data suggest the presence of common neutraliza-
tion epitopes between SA and Indian viruses although
there is also evidence for regional neutralization deter-
minants within subtype C. The finding that SA viruses
were generally neutralized at higher titers, suggests that
the exposure of common epitopes on envelope may vary
between SA and Indian viruses. Overall, these data sup-
port the development of a subtype C-specific vaccine
that can be used in both SA and India.
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